Rare genetic variants and the risk of cancer

Current Opinion in Genetics and Development

Volumn 20, Issue 3, 2010, Pages 262-267

  Bodmer, Walter ^a   Tomlinson, Ian ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHECKPOINT KINASE 2; PROTEIN BRIP2; PROTEIN PALB2; UNCLASSIFIED DRUG; CHEK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; FAMILIAL CANCER; FUNCTIONAL ASSESSMENT; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HERITABILITY; HUMAN; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOLID TUMOR; STATISTICAL ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MUTATION; NEOPLASM; RISK FACTOR;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MUTATION; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; CHECKPOINT KINASE 2;

EID: 77953621982     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2010.04.016     Document Type: Review

References (17)

1. Carvajal-Carmona L.G., Churchman M., Bonilla C., Walther A., Lefevre J.H., Kerr D., Dunlop M., Houlston R., Bodmer W.F., Tomlinson I. Comprehensive assessment of variation at the transforming growth factorbeta type 1 receptor locus and colorectal cancer predisposition. Proc Natl Acad Sci USA 2010.
2. Valle L., Serena-Acedo T., Liyanarachchi S., Hampel H., Comeras I., Li Z., Zeng Q., Zhang H.T., Pennison M.J., Sadim M., et al. Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 2008, 321:1361-1365.
3. Xu Y., Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007, 16 Spec No 1:R14-20.
4. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008, 40:695-701.
5. Dickson S.P., Wang K., Krantz I., Hakonarson H., Goldstein D.B. Rare variants create synthetic genome-wide associations. PLoS Biol 2010, 8:e1000294.
6. Frikke-Schmidt R. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population. Atherosclerosis 2010, 208:305-316.
7. Eyre-Walker A. Evolution in health and medicine Sackler colloquium: genetic architecture of a complex trait and its implications for fitness and genome-wide association studies. Proc Natl Acad Sci USA 2010, 107 Suppl 1:1752-1756.
8. Gorlov I.P., Gorlova O.Y., Sunyaev S.R., Spitz M.R., Amos C.I. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet 2008, 82:100-112.
9. Renwick A., Thompson D., Seal S., Kelly P., Chagtai T., Ahmed M., North B., Jayatilake H., Barfoot R., Spanova K., et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 2006, 38:873-875.
10. Easton D.F., Deffenbaugh A.M., Pruss D., Frye C., Wenstrup R.J., Allen-Brady K., Tavtigian S.V., Monteiro A.N., Iversen E.S., Couch F.J., et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 2007, 81:873-883.
11. Martinez S.L., Kolodner R.D. Functional analysis of human mismatch repair gene mutations identifies weak alleles and polymorphisms capable of polygenic interactions. Proc Natl Acad Sci USA 2010, 107:5070-5075.
12. Fearnhead N.S., Wilding J.L., Winney B., Tonks S., Bartlett S., Bicknell D.C., Tomlinson I.P., Mortensen N.J., Bodmer W.F. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci USA 2004, 101:15992-15997.
13. Rahman N., Seal S., Thompson D., Kelly P., Renwick A., Elliott A., Reid S., Spanova K., Barfoot R., Chagtai T., et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007, 39:165-167.
14. Seal S., Thompson D., Renwick A., Elliott A., Kelly P., Barfoot R., Chagtai T., Jayatilake H., Ahmed M., Spanova K., et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 2006, 38:1239-1241.
15. Thompson D., Seal S., Schutte M., McGuffog L., Barfoot R., Renwick A., Eeles R., Sodha N., Houlston R., Shanley S., et al. A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiol Biomarkers Prev 2006, 15:2542-2545.
16. Meindl A., Hellebrand H., Wiek C., Erven V., Wappenschmidt B., Niederacher D., Freund M., Lichtner P., Hartmann L., Schaal H., et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 2010, 42:410-414.
17. Jones S., Hruban R.H., Kamiyama M., Borges M., Zhang X., Parsons D.W., Lin J.C., Palmisano E., Brune K., Jaffee E.M., et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009, 324:217.